CHTR vs CTSO · P/E 11, rev $55.09B vs $28.8M cap
Charter Communications Inc (CHTR) versus Cytosorbents Crp (CTSO) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
CTSO does not have a complete income-statement cache yet.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. CTSO currently screens at market cap $28.8M.
Not investment advice. Open the CHTR and CTSO stock pages for the full models.
Not investment advice.